From: A comprehensive review of the benefits of Taraxacum officinale on human health
Medicinal properties of Taraxacum officinale | References |
---|---|
Diuretic activity and treatment of urological diseases | Clare et al. (2009), Ghale-Salimi et al. (2018), Karakus et al. (2017), Râcz–Kotilla et al. (1974) |
Hepatoprotective effects | Cai et al. (2017), Colle et al. (2012); Davaatseren et al. (2013a), Davaatseren et al. (2013b), Hfaiedh et al. (2016), Park et al. (2010), You et al. (2010) |
Treatment of colitis | Chen et al. (2019a), Chen et al. (2019b), Ding and Wen (2018), Han et al. (2017), Wang et al. (2017) |
Effects on the immune system | Kim et al. (1998), Lee et al. (2012), Sang et al.(2019), Tan et al.(2017) |
Antiviral effects | Flores-Ocelotl et al. (2018), Han et al. (2011), He et al. (2011), Rehman et al. (2016), Yang et al. (2020) |
Antifungal activity | Liang et al. (2020) |
Antibacterial activity | Diaz et al. (2018), Kenny et al. (2015), Qian et al. (2014), Wang (2014) |
Antiarthritic activity | Wang et al. (2016) |
Antidiabetic effects | Akhtar et al. (1985), Choi et al. (2018), Davaatseren et al. (2013b), Guo et al. (2019), Hussain et al. (2004) |
Antiobesity activity | Aabideen et al. (2020), Choi et al. (2010), GarcÃa-Carrasco et al. (2015), Davaatseren et al. (2013b), Râcz–Kotilla et al. (1974), Zhang et al. (2008) |
Antioxidant activity | Aabideen et al. (2020), Choi et al. (2010), GarcÃa-Carrasco et al. (2015), Guo et al. (2019), Hu and Kitts (2005), Ivanov et al. (2018), Jedrejek et al. (2017), Jedrejek et al. (2019), Lis et al. (2020), Milek et al. (2019), Park et al. (2011), Park et al. (2014) |
Anticancer effects | Nassan et al. (2018), Nguyen et al. (2019), Ovadje et al. (2011), Ovadje et al. (2012), Ovadje et al. (2016), Saratale et al. (2018), Sigstedt et al. (2008) |